AvidBiotics raises $1M for anti-infective drugs
November 7, 2007 | David P. Hamilton
See our story about this South San Francisco, Calif., biotech in Monday’s daily briefing at VentureBeat Life Sciences.
Next Story: Real estate site Trulia showing momentum; Is Zillow in trouble?
Previous Story: Aryx discounts IPO price, raises up to $58M for safer drugs
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
VB Writers
East Coast Editor
Dean TakahashiLead Writer, GamesBeat
National Editor, MobileBeat Lead
Executive Editor
Editor-in-Chief, GamesBeat
Senior Editor
Writer
Writer
Founder & Editor-in-Chief
Writer
Editorial Assistant
Writer
Reviews Editor, GamesBeat
Tom CheredarWriter
Contributor
Julia PlevinContributor
Contributor









